Clinical Trial Update: Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma [NA]

View source ↗

Summary

Clinical trial comparing transarterial chemoembolization (TACE) plus sorafenib versus TACE alone for advanced hepatocellular carcinoma; phase and current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Advanced Hepatocellular Carcinoma | NA | Status: UNKNOWN